Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...

Avanza Fonder AB reduced its stake in Amgen by 15.2% in Q1, selling nearly 9,000 shares but still holding $15.3 million. The biotech behemoth remains the 28th largest holding for Avanza, proving it's ...

In the latest close session, Amgen (AMGN) was up +1.88% at $297.29. The stock outpaced the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.24%, and the technology-dominated ...

Wesbanco Bank just pumped up its Amgen stock by 23.2%, scooping up over 64,000 shares worth nearly $20 million. This ...

Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 9:20 PM ETCompany ParticipantsJames E.

Amgen Inc. closed 15.40% below its 52-week high of $346.85, which the company reached on July 25th.

Amgen Manufacturing Limited LLC has received the U.S. Environmental Protection Agency’s Energy Star certification for its facility in Juncos, Puerto Rico, placing it among the most energy-efficient ...

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin ...

Last week, federal jurors in Delaware awarded Regeneron Pharmaceuticals Inc. more than $400 million in its antitrust showdown with Amgen Inc., the company’s rival in the market for cholesterol ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best performing Dow stocks so far in 2025. The Dow is a renowned and significant stock market ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...